missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. 17312439

DiscoverX Recombinant Human Complement C5a

Product Code. 17312439
Encompass
Click to view available options
:
25 μg
This item is not returnable. View return policy

Product Code. 17312439

Brand: DiscoverX 921103

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Recombinant Human Complement C5a is an agonist for C5AR1 and C5AR2. Provided as 25μg of dry powder alongside reconstitution buffer.

Complement Component 5a (C5a) is a pro-inflammatory protein fragment anaphylatoxin, and is cleaved by C5-convertase from complement component C5. Acting as an agonist for C5AR1 and C5AR2 on macrophages, neutrophils, and endothelial cells, C5a is a strong chemoattractant in stimulating an inflammatory response, and is recruited with the complement system network during an immune response to tissue damage or foreign objects. It is widely involved in many forms of inflammatory diseases, including asthma, ischemia-reperfusion injury, acute lung injury, and sepsis. Provided as 25μg of dry powder alongside reconstitution buffer.

Specifications

Quantity 25 μg
Product Type Control Ligands
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.